(HealthDay News) — Tulisokibart, a tumor necrosis factor-like cytokine 1A monoclonal antibody, is more effective in inducing clinical remission in patients with moderately to severely active ...

(HealthDay News) — Use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with the risk for retained gastric contents and inadequate bowel preparation during endoscopic procedures, ...

The approval was based on data from the BLUE-C trial, which assessed the sensitivity and specificity of the Cologuard Plus test vs FIT in asymptomatic adults scheduled for screening colonoscopy.

The alert follows an announcement from the US DOJ regarding the indictment of 18 individuals who operated a network of fake online pharmacies and pill mills.

The US Department of Health and Human Services has set a goal that at least 95% of children in kindergarten get 2 doses of the measles-mumps-rubella (MMR) vaccine, a threshold that helps prevent ...

(HealthDay News) — Harmful diagnostic errors (DEs) occur in an estimated one of every 14 hospitalized general medicine patients, according to a study published online Oct. 1 in BMJ Quality & Safety.